CPGShield resources · Claims
A cosmetic founder can launch a product without submitting every claim to FDA for approval first.
That sounds like freedom. Operationally, it creates risk.
FDA states that cosmetic labeling does not need FDA approval before cosmetic products go to market, and the agency does not maintain a list of approved cosmetic claims. But the same FDA guidance makes the other half of the rule equally clear: cosmetic labeling must be truthful and not misleading, and certain claims can cause a product to be regulated as a drug.
That means the label is not simply describing the product. It is helping define what the product legally is.
Consider two anti-aging statements:
Those phrases may sound like variations on the same marketing idea. From a regulatory perspective, they can be very different.
FDA explains that products intended merely to make someone look more attractive can be cosmetics. A moisturizer that makes wrinkles appear less noticeable through hydration can fit comfortably within the cosmetic category.
But a claim that a product removes wrinkles, changes the skin's structure, or increases collagen production can suggest an effect on the structure or function of the body. That is drug or device territory.
This is the part of cosmetic compliance that founders often underestimate: the risk is not limited to obviously medical words.
The carton is not the only place where intended use can be established.
FDA says intended use can be demonstrated by claims in product labeling, advertising, internet materials, and other promotional content. Consumer perception and certain ingredients can matter too.
So a team can carefully clean up the package and still create regulatory exposure on:
This is why a claims review cannot be treated as a final proofreading exercise.
The beauty industry uses the word "cosmeceutical" constantly.
FDA does not.
The agency states that the Federal Food, Drug, and Cosmetic Act does not recognize "cosmeceutical" as a legal category. A product can be a cosmetic, a drug, or both.
That matters because founders sometimes use "cosmeceutical" as shorthand for "stronger than a cosmetic but not really a drug." Legally, that middle ground does not exist simply because the marketing team gives it a name.
Claims review is step 6 of the 2026 U.S. cosmetic label compliance checklist; the retailer side of the same question is covered in FDA compliant does not mean retailer compliant.
The wrong question is:
"Does this claim sound reasonable?"
The better questions are:
There is no one-word blacklist that solves this. Context matters.
CPGShield supports pre-print review with covered claims checks, supported text changes and reports for review. A text scan is free; the standalone Marketing Claims Check costs one check credit.
Review claim wording while the label is still a draft. That gives your team an opportunity to revise it before printing, filling, shipping or publishing retailer content.
The point is not to make cosmetic marketing timid. The point is to know when a sentence creates a different regulatory consequence than the team intended.
Question for cosmetic founders: when your marketing copy changes during a launch, does the compliance review automatically happen again-or only if somebody remembers to ask?
Free cosmetic label compliance check. No demo required, no card. CPGShield LLC provides independent screening. We are not affiliated with, endorsed by, or acting for any retailer, brand, agency or organization we name.